Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-9,293
Closed -$285K – 746
2024
Q4
$285K Sell
9,293
-2,614
-22% -$86.9K 0.03% 589
2024
Q3
$448K Buy
+11,907
New +$459K 0.04% 531
2019
Q1
– Sell
-6,300
Closed -$236K – 438
2018
Q4
$236K Buy
+6,300
New +$246K 0.01% 387
2015
Q4
– Sell
-27,771
Closed -$830K – 430
2015
Q3
$830K Buy
+27,771
New +$909K 0.02% 764

Other funds holding ATEX

PDT Partners's ATEX Position: Q1 2025 in Review

PDT Partners sold out of Anterix (ATEX) in Q1 2025, closing a stake of 9,293 shares — an estimated $285K sold.

PDT Partners first reported a position in ATEX in Q3 2015 and held it in 4 quarters. The position peaked at $830K in Q3 2015. 128 funds tracked by Wall St. Rank hold ATEX as of Q1 2025.

  • PDT Partners reported no remaining Anterix position as of Q1 2025 after selling out during the quarter.
  • PDT Partners sold 9,293 Anterix shares in Q1 2025, an estimated $285K.
  • PDT Partners first reported a position in Anterix in Q3 2015 and held it in 4 quarters.
  • PDT Partners's Anterix position peaked at $830K in Q3 2015.
  • 128 funds tracked by Wall St. Rank held Anterix as of Q1 2025.

Based on PDT Partners's 13F filing for Q1 2025, filed 15 May 2025.